Clinical Trial Update: Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating treatment in elderly patients (over 65) with adult acute lymphocytic leukemia (ALL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Leukemia

Snippet

Sponsor: Goethe University | Conditions: Adult Acute Lymphocytic Leukemia | Phase 4 | Status: COMPLETED